May 22, 2013

Weather

Fair

64°
Conditions at North Texas Regional Airport, TX
Save Email Print Bookmark and Share
A A
Reporter: Nicole Holt Email

HPV - A candid discussion

You've heard the controversy over the new HPV vaccine. Now we're getting to the truth of the matter. What is it? How does it really impact your life and your children's lives? Dr. DeAnn Strobel stopped by for a candid discussion.

Then send in your questions to nicole.holt@kxii.com, and we'll get them answered on First News AM all week.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus

WebMD Health News

AP Top Health Stories

  • Cancer Society hits 100 as US cancer rate falls

    FILE - In this Nov. 15, 1979 file photo, United States Surgeon General Dr. Julius B. Richmond, at the microphones, kicks off the third annual "Smokeout" rally sponsored by the American Cancer Society in Washington, D.C. as a part of the "Great American Smokeout Day." (AP Photo)NEW YORK (AP) — The American Cancer Society — one of the nation's best known and influential health advocacy groups — is 100 years old this week.


  • Life-saving face transplant performed in Poland
    WARSAW, Poland (AP) — Doctors in Poland say they have performed an urgent total face transplant on a 33-year-old man whose face was torn off in an accident which also crushed his jaws.
  • Portland, Ore., rejecting water fluoridation
    PORTLAND, Ore. (AP) — The mayor of Portland, Ore., has conceded defeat in an effort to add fluoride to the city's drinking water.
  • Synthetic Peas Soothe Achy Joints
    Sir Isaac Newton found his inspiration in an apple.  MaryCarol Dolivier found hers in a bag of frozen peas. After Dolivier tumbled down a flight of stairs a few years ago she was forced to lay on the couch for several weeks, a bag of...        
  • Oncolytics cancer drug meets mid-stage trial goal, shares rise
    (Reuters) - Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock Exchange on Wednesday. Its Nasdaq-listed shares were up 10 percent. ...